← Evidence map

ArticleCell reports2024

RPL22 is a tumor suppressor in MSI-high cancers and a splicing regulator of MDM4.

Hannah N W Weinstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

15 papers cite it

2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39146182